Literature DB >> 481452

Mutagenicity, cytotoxicity and DNA crosslinking in V79 Chinese hamster cells treated with cis- and trans-Pt(II) diamminedichloride.

L A Zwelling, M O Bradley, N A Sharkey, T Anderson, K W Kohn.   

Abstract

The mutagenicity and cytotoxicity of cis- and trans-Pt(II) diamminedichloride (PDD) were examined in V79 Chinese hamster lung cells and compared with effects on DNA measured by alkaline elution. DNA--protein crosslinks and DNA interstrand crosslinks were detected following doses of cis-PDD which reduced cell survival 80--90% and which produced a mutant frequency of 3 X 10(-4) at the HGPRT locus. Equitoxic doses of trans-PDD were much less mutagenic than cis-PDD. At equitoxic doses, trans-PDD produced more DNA-protein crosslinking than did cis-PDD, but interstrand crosslinking for the two isomers was comparable. Hence, the interstrand crosslink could be the cytotoxic lesion produced by these Pt compounds whereas neither of these DNA lesions are necessarily mutagenic. The mutagenesis produced by cis-PDD could be due to crosslinks of a different type than those produced by trans-PDD or it may be due to monofunctional damage.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 481452     DOI: 10.1016/0165-1218(79)90021-1

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  12 in total

1.  Error-prone replication of a 5-formylcytosine-mediated DNA-peptide cross-link in human cells.

Authors:  Spandana Naldiga; Shaofei Ji; Jenna Thomforde; Claudia M Nicolae; Marietta Lee; Zhongtao Zhang; George-Lucian Moldovan; Natalia Y Tretyakova; Ashis K Basu
Journal:  J Biol Chem       Date:  2019-05-28       Impact factor: 5.157

2.  A new assay for functional screening of BRCA2 linker region mutations identifies variants that alter chemoresistance to cisplatin.

Authors:  Curtis R Warren; Zohra Ali-Khan Catts; Mary C Farach-Carson
Journal:  Exp Cell Res       Date:  2011-06-29       Impact factor: 3.905

3.  Error-prone translesion synthesis mediates acquired chemoresistance.

Authors:  Kun Xie; Jason Doles; Michael T Hemann; Graham C Walker
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-10       Impact factor: 11.205

4.  Cross-linking of the DNA repair protein O6-alkylguanine DNA alkyltransferase to DNA in the presence of cisplatin.

Authors:  Xun Ming; Erin D Michaelson-Richie; Arnold S Groehler; Peter W Villalta; Colin Campbell; Natalia Y Tretyakova
Journal:  DNA Repair (Amst)       Date:  2020-03-19

5.  Pharmacokinetic study of cerebrospinal fluid penetration of cis-diamminedichloroplatinum (II).

Authors:  P E Gormley; D Gangji; J H Wood; D G Poplack
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

6.  Results of a randomized trial comparing intra-arterial cisplatin and intravenous PCNU for the treatment of primary brain tumors in adults: Brain Tumor Cooperative Group trial 8420A.

Authors:  E M Hiesiger; S B Green; W R Shapiro; P C Burger; R G Selker; M S Mahaley; J Ransohoff; J C VanGilder; J Mealey; J T Robertson
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

7.  Base-pair substitution hotspots in GAG and GCG nucleotide sequences in Escherichia coli K-12 induced by cis-diamminedichloroplatinum (II).

Authors:  J Brouwer; P van de Putte; A M Fichtinger-Schepman; J Reedijk
Journal:  Proc Natl Acad Sci U S A       Date:  1981-11       Impact factor: 11.205

8.  In vitro assessment of the toxicity of metal compounds : II. Mutagenesis.

Authors:  J D Heck; M Costa
Journal:  Biol Trace Elem Res       Date:  1982-12       Impact factor: 3.738

9.  Cytogenetic toxicity of antitumor platinum compounds in Fanconi's anemia.

Authors:  E H Poll; F Arwert; H Joenje; A W Eriksson
Journal:  Hum Genet       Date:  1982       Impact factor: 4.132

Review 10.  Effects of metals in in vitro bioassays.

Authors:  M A Sirover
Journal:  Environ Health Perspect       Date:  1981-08       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.